Mandatory Rest Period

Another oral med is moving forward and testing against Avonex too.

"Active Biotech and Teva have announced they are enrolling patients on to a pivotal phase-three trial of the oral compound laquinimod.

The Bravo trial will involve approximately 1,200 relapsing-remitting multiple sclerosis patients and will evaluate laquinimod against the currently-available Avonex as well as a placebo.

A second phase-three trial of the compound with 1,000 patients is also underway, Teva reported.

Dr Timothy Vollmer, principal Bravo investigator and medical director at the Rocky Mountain MS Centre in Denver, Colorado, pointed out that all currently-approved multiple sclerosis (MS) treatments are administered by injection or infusion.

He continued: "The ability to provide a safe and effective oral treatment option would be a significant advancement for the treatment of MS."

- posted by Anonymous @ 12:44 PM - Link @ 12:44 PM - Link to this post - Comments (0)

			Hi, I’m Kim! This site provides a little insight to my journey of being diagnosised with Remitting Relapsing Multiple Sclerosis on October 26th 2004. I review books and documentaries, post MS-related news, and share my photos. Subscribe (RSS) My bloglines Archives Current November 2004 December 2004 January 2005 February 2005 March 2005 April 2005 May 2005 June 2005 July 2005 August 2005 September 2005 October 2005 November 2005 December 2005 January 2006 February 2006 March 2006 April 2006 May 2006 June 2006 July 2006 August 2006 September 2006 October 2006 November 2006 December 2006 January 2007 February 2007 March 2007 April 2007 May 2007 June 2007 July 2007 August 2007 September 2007 October 2007 November 2007 December 2007 January 2008 February 2008 March 2008 April 2008 May 2008 June 2008 July 2008 August 2008 September 2008 October 2008 November 2008 December 2008 January 2009 February 2009 March 2009 April 2009 May 2009 June 2009 July 2009 August 2009 September 2009 October 2009 November 2009 December 2009 January 2010 February 2010 March 2010 May 2010 June 2010 July 2010 September 2010 November 2011

	Wednesday, July 16, 2008 *Laquinimod Phase III trials starting* Another oral med is moving forward and testing against Avonex too. "Active Biotech and Teva have announced they are enrolling patients on to a pivotal phase-three trial of the oral compound laquinimod. The Bravo trial will involve approximately 1,200 relapsing-remitting multiple sclerosis patients and will evaluate laquinimod against the currently-available Avonex as well as a placebo. A second phase-three trial of the compound with 1,000 patients is also underway, Teva reported. Dr Timothy Vollmer, principal Bravo investigator and medical director at the Rocky Mountain MS Centre in Denver, Colorado, pointed out that all currently-approved multiple sclerosis (MS) treatments are administered by injection or infusion. He continued: "The ability to provide a safe and effective oral treatment option would be a significant advancement for the treatment of MS." - posted by Anonymous @ 12:44 PM - Link @ 12:44 PM - Link to this post - Comments (0)